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Summary.-Immunoglobulin levels (IgA, IgG, IgM) have been estimated in protein
extracts of 55 malignant and 20 benign tumours of the breast, and in 17 normal
tissues from a cancer bearing breast. IgA and IgG were significantly reduced in
cancer compared with both benign and normal tissues but IgM, detected in only
a third of tumours, was significantly increased. Total immunoglobulin levels and
IgG in the malignant tumours correlated with plasma cell infiltration.
The menstrual status of the patient had no influence on these findings.
EXTERNAL secretions contain immuno-
globulins in concentrations different from
those in serum, indicating the presence
of a distinct secretory immune system
(Tomasi, 1972). These antibodies are
thought to be protective to the epi-
thelium from which they are secreted.
Experimentally, local immunoglobulin
production may be greatly enhanced
by antigenic stimulation of an area of
epithelium, for example by bacterial
antigen in the lactating mammary gland
or intestinal wall (McDowell and Lascelles,
1969; Felsenfeld, 1969). This is accom-
panied by an influx ofplasma and lympho-
cytic cells into the submucosal and inter-
stitial tissues.
The predominant antibody in all
human secretions, including milk and
colostrum, is immunoglobulin A (JgA)
which is synthesized in the submucosal
plasma cells and linked with a secretory
" piece" in the epithelial cells. A defi-
ciency in local secretory IgA production
is known to occur in ulcerative colitis
(Gelzayd et al., 1968) and in coeliac
disease (Beale et al., 1971). In both these
conditions (Storrer, 1969; Doll and Kin-
len, 1970), in patients with congenital
agammaglobulinaemia (Medical Research
Council Working Party, 1969) and in
those with selective IgA deficiency (Tomasi
and Grey, 1972) there is an increased
risk of cancer. The role of secretory
immunoglobulins in breast cancer has not,
to our knowledge, been studied but in
patients with breast cancer, serum IgA
concentrations were found by Hughes
(1971) to be in the normal range, although
Rowinska-Zakrewska, Lazar and Burtin
(1970) reported them to be raised. Serum
immunoglobulin levels may not reflect
local antibody production in the tissue,
and therefore our present study set out
to investigate (1) the immunoglobulin
levels in breast cancer compared with
benign breast tissue and (2) whether
tumour immunoglobulin levels were re-
lated to the plasma and round cell
infiltrate sometimes seen in the stroma.
MATERIALS AND METHODS
Serum was obtained, when possible,
from patients on the day before operation,
and stored at -20°C. Tissues were obtained
immediately after operation and were kept
on ice. Fat was carefully removed and a
representative slice of tissue was taken and
fixed in formol alcohol for subsequent
histological studies.
In those cases where the whole mastec-
tomy specimen was available tissue was
cut from a site as far away from the tumour
as possible for normal control studies. This270 M. M. ROBERTS, E. M. BASS, I. W. J. WALLACE AND A. STEVENSON
was taken only from breasts containing
macroscopic glandular areas; if the tumour
was isolated in an entirely fatty breast,
control tissue was not taken.
Milk was obtained from one patient
within a week of parturition. Breast cyst
fluid was obtained from 4 patients by
aspiration, or at operation, together with
serum from two patients.
Preparation of tissue extract.-A piece
of tissue weighing 1-0 g was homogenized
at high speed in a Silversen homogenizer.
The homogenate was centrifuged at 250 g
for 5 minutes to remove debris and fat and
then centrifuged at 100,000 g for 11 hours
to give a final supernatant solution and a
small pellet of sediment. In the early
part of the study, homogenization of the
tissue was carried out in water and the final
supernatant was evaporated by a constant
cold air current to 1 ml in volume. Subse-
quently, we followed the method described
by Edynak, Lardis and Vrana (1971) in
which homogenization was carried out in
phosphate buffered saline (pH 7.2) and the
final supernatant was dialysed against Tris-
HCI buffer (pH 7.5) overnight, lyophilized
and redissolved in 1 ml of water. In both
methods the sediment obtained was sus-
pended in 1 ml ofnormal saline.
Protein content.-The total concentration
of soluble protein in the supernatants and
the sediment suspensions was estimated by
the Folin Ciocalteau method of Lowry et
al. (1951) using the SP 600 spectrophoto-
meter.
Immunoglobulin content.-The concentra-
tion of the 3 major classes of immuno-
globulins IgA, IgG and IgM were determined
in serum, supernatants, sediment suspensions,
milk and cyst fluid by the radial immuno-
diffusion technique of Mancini, Carbonara
and Heremans (1965) using standard Tripar-
tigen plates containing rabbit anti-human
IgA, IgG and IgM respectively. The sum
of these 3 immunoglobulins is referred to in
this paper as " total immunoglobulin ".
Histological sections.-Two sections were
prepared from each tissue, one stained with
haematoxylin and eosin (H. & E.), the other
with methyl green pyronine (MGP).
All were examined by one of us
(I.W.J.W.) who had no knowledge of the
patients or of any of the results of the
immunoglobulin estimations. The degree of
round cell infiltration was determined in
the H. & E. sections and graded as marked
(++), moderate (+) and minimal (-)
as previously described (Champion, Wallace
and Prescott, 1972). Plasma cells were
counted in 20 high power fields using MGP
stained sections and the degree of infiltration
graded as above.
Patients studied
Benign.-The tissues of 20 patients with
benign disease of the breast have been
studied. Five had fibroadenomata, 13 had
fibroadenosis and/or fibrocytic disease of the
breast, and 2 were young men with gynaeco-
mastia. Serum was available from 12 female
and both male patients.
Cancer.-Fifty-five malignant tumours
from 53 patients have been studied. All
patients were undergoing mastectomy for
primary cancer of the breast of International
(TNM) Stage I or II. In 17 patients with
19 tumours normal control tissue was
available from the tumour bearing breast.
In these cases cancer and normal tissue
were processed by the same method and at
the same time. Serum was available from
15 of these and also from 12 patients in
whom no normal tissue was obtained.
RESULTS
Comparison of methods
A comparison of total protein and
immunoglobulin concentrations in the
supernatants of 37 breast cancers pre-
pared by saline and 18 by water extrac-
tion, is shown in Table I. No significant
differences were observed, nor was there
any difference in the results in 2 tumours
in which both methods were used.
Comparison ofprotein and immunoglobulin
content ofsupernatant and sediment suspen-
sions
Total protein was estimated in all
supernatants and in most of the sediment
suspensions. In the latter the results
were considered unreliable because the
solution obtained by redissolving the
sediment was cloudy and contained parti-
culate matter. No direct comparison has
been made between the two sets of
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5 cases total protein in the supernatant
far exceeded that in the deposit. There
were no detectable immunoglobulins in
24 of 52 tumour sediments studied and a
further 24 had levels less than one-third
of those found in the corresponding
supernatants. In the other 4 tumour
sediments the immunoglobulin levels were
higher than in the corresponding super-
natant, as was the total protein content.
Comparison of benign and malignant
tumours
In Table II we have compared the
results of total protein *and immuno-
globulin estimations in the supernatants
of benign and malignant tumours accord-
ing to the menstrual status ofthe patient.
Significant reductions in immunoglobulin
content of malignant tissues were ob-
served. Similar levels were found in
cancers from pre- and postmenopausal
women.
Comparison of malignant tumours and
" normal" tissue
Total immunoglobulin, IgA and IgG
levels in normal and malignant tissue
from the same breast have been com-
pared by a paired " t " test. The cancer
tissue results, shown in Table III, indi-
cated significantly lower immunoglobulin
TABLE I.-Total Protein (g/100 ml), Total Immunoglobulins and IgA and IgGFractions
(Expressed as a Percentage of the Total Protein) in Supernatants Prepared by Saline
and Water Extraction. Mean Values and Standard Errors of the Means are Shown.
Differences were not Significant. Total Immunoglobulin Refers to the Sum of IgA,
IgG and IgM Levels
Total
immunoglobulin
(% total protein)
8-23+0-61
8i68±1-50
IgA
(% total protein)
1 49+0 16
1-39±0-48
IgG
( % total protein)
6-53+0-51
6-74±1 -20
TABLE II.-Immunoglobulin Levels (as a Percentage of the Total Protein) in the Super-
natants of Benign and Malignant Tissues According to the Menstrual Status of the
Patient. Only Women Over the Age of 30 are Included in this Table. Mean Values
and Standard Errors of the Means are Shown. All Tissues were Extracted by Saline
Total protein
No. (g/100 ml)
Pre-menopausal
Benign
Malignant
" P " value
Total
immunoglobulin IgA IgG
(% total protein) (% total protein) (% total protein)
10 . 1-66±0-17 . 13-00±0-80
11 . 1-51±0-21 . 7-56±0-95
* - * - < 0 0005
3-74±0-40
1-54±0-37
<0-0005
Post-menopausal
Malignant 22 . 1-28+0-20 8-31+0-80 1-52+0-21 . 6-54+0-69
TABLE III.-Comparison of Immunoglobulin Levels in Normal and Malignant Tissue
Obtained from the Same Breast in 17 Patients. Two patients had 2 Tumours in
the Same Breast which were Analysed Separately. Mean Values and Standard
Errors of the Means are Shown
Tumour from
same breast
Normal
Tumour
" P " value
Total immunoglobulin
No. (% total protein)
17 12-30+1*27
19 . 8-61±1-17
IgA
( % total protein)
3 47±0 66
1- 62+0-29
< 0
- 0025 . <0*025
IgG
(% total protein)
8-63+0-74
6-71±1 -00
<0*0025
Supernatant
Saline extract
Water extract
No.
37
18
Total protein
(g/100 ml)
1 35±013
1*17±0*27
9-02±0-58
5-80+0 68
<0-0025
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levels than did normal tissue of the
same breast. The menstrual status of
the patient did not have any effect on
the immunoglobulin levels in the normal
tissues, which were similar to those found
in the premenopausal benign tissues
described above.
Comparison of milk, cyst fluid, serum and
tissue levels of IgA
The IgA level in our sample of milk
was 424 mg/100 ml, which represented
91% ofthe total immunoglobulin measur-
ed. This is approximately 10 times
the concentration normally found in
serum.
In breast cyst fluid the immuno-
globulin levels were found to be very low
or absent. The mean total immuno-
globulin in the 4 cysts formed only 1% of
the estimated total protein.
In order to obtain a ratio so that tissue
levels of IgA could be compared directly
with serum levels, IgA was expressed
as a fraction of the total immunoglobulin
determined.
The mean value of the IgA fraction
in benign tumours and in normal tissue
compared by a paired " t " test was
significantly greater than the correspond-
ing mean value in serum, shown in
Table IV. There was no difference be-
tween the mean values in cancers and
the corresponding sera. However, in
Fig. 1 the individual results of cancers
and their matching normals are shown.
In two-thirds of tumours the IgA fraction
was lower than in the corresponding
serum, whereas in the other one-third the
fraction was similar to the normal tissue
fraction.
IgA
as
fraction
of
total
BENIGN
(10)
.R
tissue serum tissue serum tissue serum
FIG. 1.-IgA expressed as a fraction of total
immunoglobulin (supernatant andsediment
levels combined) in benign, normal and
corresponding cancer tissues compared with
IgA serumfraction. Total immunoglobulin
is the sum ofIgA, IgG and IgM.
In Fig. 1 only those tumours with
normal tissue controls are shown. When
all 27 cancer serum and tissue values
were compared similar results were found.
Neither of the gynaecomastia tissues
showed local concentration of IgA in
excess of that found in their sera.
Tumours containing IgM
IgM was detected in 19 of the 55
malignant tumours, in 6 of the 17 normal
and in 4 of the 20 benign tissues. The
TABLE IV.-IgA Expressed as Percentage of the Total Immunoglobulin (IgA + IgG +
1gM) Determined in Tissues and Corresponding Sera. The Mean Values and
Standard Errors of the Means are Shown
Benign Normal Cancer
Tissue Serum Tissue Serum Tissue Serum
27-7±43-4 13-2±1-4 . 28-4±3-9 14-7±1-9 . 14-2i1-7 14-7±1-2
<0-0025 < 0-0025
IgA fraction
" P " value .
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FIG. 2.-Comparison of absolute values of IgAM
(mg%) obtained from 1 g malignant tumour
tissue with levels in control tissues (benign
and normal). Supernatant and sediment
levels are combined. The means and s.e.
mean are shown. (P < 0 025.)
levels usually were low and are shown
in Fig. 2, expressed as absolute values
(mg/100 ml obtained from 1 g of tissue).
The mean level ofIgM was significantly
higher in the cancers (37.1 ± 7.1) com-
pared with benign and normal levels
combined (6.5 ± 1-2). Because of this
finding, we have looked at the tissue
IgM fraction and compared it with the
serum IgM fraction in 10 patients from
whom serum was available. The results
(Fig. 3) show that the tissue IgM fraction
was higher in 6 cancers than in the cor-
responding serum, whereas this was never
the case in benign or normal tissues.
Tumour imrnunoglobulin levels and plasma
and round cell infiltration
The supernatant immunoglobulin
levels in tumours with marked, moderate
tissue serum tissue serum
FIG. 3. IgM expressed as a fraction of total
immunoglobulin obtained from each cancer
and control tissue is compared with its corre-
sponding serum fraction. A, B and C refer
to the same patients.
and minimal round cell and plasma cell
infiltration are shown in Fig. 4. Cancers
with a marked plasma cell infiltrate had
significantly higher total immunoglobulin
and IgG levels than did those with
minimal infiltrate (P<0.025 and P<0025
respectively). These findings were similar
with respect to round cell infiltration.
IgA levels did not reflect the degree
of infiltration. Mean levels of IgM were
too low to allow comparison.
In the 3 intraduct cancers included
in the series, the immunoglobulin levels
and plasma cell infiltration showed pat-
terns similar to those in tumours which
had spread into the adjacent tissues.
DISCUSSION
The two methods ofpreparation appear
to be equally efficient in extracting soluble
protein from the tissues. In almost all
cases, it was found that most of the
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FIG. 4.-Supernatant total immunoglobulin, IgA, IgG and IgM levels as a percentage of the total
protein, are shown in tumours with marked (++), moderate (+) and minimal (-) plasma cell and round cell infiltration.
soluble protein and immunoglobulins were
in the supernatant fraction.
We have used a standard antiserum
to serum IgA in order to estimate IgA
levels in tissues. This method is not
specific for secretory IgA but specific
antiserum was not available at the time
of this study. As the result depends
on the availability of all the antigenic
terminals of the IgA molecule, it will
give a level of total secretory and serum
IgA in the tissues.
We have shown that breast cancer
tissue contains significantly less IgA and
IgG than benign or corresponding control
breast tissue and this is not related to the
menstrual status of the patient. As the
remainder of the tumour-bearing breast
has similar immunoglobulin levels to
those of benign tissues, it seems unlikely
that the malignancy has occurred because
there is an abnormality of IgA secretion
in the epithelium of the ducts of that
breast. Conversely, we have shown that
IgA synthesis is not stimulated by the
presence of tumour, even in the presence
of an infiltration of cells known to be
responsible for the production ofimmuno-
globulins.
Our finding of raised levels of IgM
in some tumours is of interest. It will
be of importance to determine whether
the presence of IgM in the tumour is
associated with a good prognosis, or
with other manifestations of host resist-
ance. It is interesting to note that
Crabbe and Heremans (1966) found in
one of 2 gastric carcinomata they studied
by immunofluorescent techniques that
IgA producing cells were reduced and
IgM producing cells were increased com-
pared with normal gastic mucosa.
Using an extraction method similar
to the one we used, Witz (1971) found
that IgG, but no other immunoglobulin,
was eluted from chemically induced sarco-
mata in rats. Although we found the
level of IgG in breast cancer tissue to be
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2
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significantly lower than in benign tissue,
it nevertheless correlated with the degree
of infiltration of plasma and round cells
in the malignant tumours. In this study,
IgA levels in the tumour did not correlate
with plasma or round cell infiltration.
In the next part of our study we hope
to elucidate further the site and specificity
of antibody production.
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